SCHEMBL7050872

SCHEMBL7050872

NC(CCc1cccc(Cl)c1)[C@@H](O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.50
TDO2 P48775 1/20 0.50
METAP2 P50579 2/20 0.49
PNMT P11086 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
TAAR1 Q96RJ0 2/20 0.46
AOC3 Q16853 1/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
TACR1 P25103 2/20 0.43
MASP2 O00187 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7051572 0.83 TAAR1 (0.46) IDO1METAP2TAAR1CSNK1E
SCHEMBL7156004 0.82 METAP2 (0.57) METAP2KMT2AMEN1HPGD
SCHEMBL7159796 0.80 TAAR1 (0.52) IDO1METAP2TAAR1AOC3
SCHEMBL8356898 0.79 PNMT (0.57) IDO1PNMTTAAR1AOC3HTR3E
SCHEMBL7092247 0.78 EPHX1 (0.58) TAAR1LMNACSNK1E
SCHEMBL7092250 0.78 EPHX1 (0.58) TAAR1LMNACSNK1E
SCHEMBL7047857 0.77 METAP2 (0.52) METAP2TAAR1CSNK1E
SCHEMBL7052637 0.77 METAP2 (0.46) METAP2KMT2AMEN1ALDH1A1CSNK1E
SCHEMBL7050427 0.77 SIGMAR1 (0.43) METAP2KMT2ACSNK1E
SCHEMBL3351268 0.76 ALDH1A1 (0.47) PNMTKMT2ATAAR1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed